Teratogen-induced eye defects mediated by p53-dependent apoptosis

Current Biology

Volumn 6, Issue 1, 1996, Pages 60-69

  Wubah, Judith A ^a   Ibrahim, Monier M ^a   Gao, Xiang ^a   Nguyen, Diep ^a   Pisano, M Michele ^a   Knudsen, Thomas B ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXY 5' ADENOSINE MONOPHOSPHATE; 2'-DEOXY-5'-ADENOSINE MONOPHOSPHATE; CLADRIBINE; DEOXYADENOSINE PHOSPHATE; PRIMER DNA; PROTEIN P53; TERATOGENIC AGENT;

ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CONGENITAL MALFORMATION; DRUG EFFECT; EYE MALFORMATION; FEMALE; GENE EXPRESSION; GENETICS; MALE; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; APOPTOSIS; BASE SEQUENCE; CLADRIBINE; DEOXYADENINE NUCLEOTIDES; DNA PRIMERS; EYE ABNORMALITIES; FEMALE; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; TERATOGENS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0029189127     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)00422-0     Document Type: Article

References (47)

1. Sulik KK, Cook CS, Webster WS: Teratogens and craniofacial malformations: relationships to cell death. Development 1988, 103 (suppl): 213-232.
2. Snow MHL, Tam PPL: Is compensatory growth a complicating factor in mouse teratology? Nature 1979, 279:555-557.
3. Gao X, Blackburn MR, Knudsen TB: Activation of apoptosis in early mouse embryos by 2′-deoxyadenosine exposure. Teratology 1994, 49:1-12.
4. Chen B, Cyr DG, Hales BF: Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro. Teratology 1994, 50:1-12.
5. Jiang H, Kochhar DM: Induction of tissue transglutaminase and apoptosis by retinoic acid in the limb bud. Teratology 1992, 46:333-340.
6. Thayer M, Mirkes PE: Programmed cell death and N-acetoxy-2-acetylaminofluorene-induced apoptosis in the rat embryo. Teratology 1995, 51:418-429.
7. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991, 51:6304-6311.
8. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993, 362:849-852.
9. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993, 362:847-849.
10. Lowe SW, Ruley HE, Jacks T, Housman DE: p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993, 74:957-967.
11. Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence J-J, et al.: p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol 1993, 13:1415-1423.
12. Hermeking H, Eick D: Mediation of c-myc-induced apoptosis by p53. Science 1994, 265:2091-2093.
13. Symonds H, Krall L, Remington L, Robles MS, Jacks T, Vandyke T: p53-dependent apoptosis in vivo - impact of p53 activation on tumorigenesis. Cold Spring Harbor Symp Quant Biol 1994, 59:247-257.
14. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991, 253:49-53.
15. Oliner JD, Kinzer KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992, 358:80-66.
16. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Jr, Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992, 356: 215-224.
17. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA: Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994, 4:1-7.
18. Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SEM, et al.: Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 1994, 9:603-609.
19. Beneviste P, Cohen A: p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency. Proc Natl Acad Sci USA 1995, 92:8373-8377.
20. Hoever M, Clement JH, Wedlich D, Montenarh M, and Knochel W: Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos. Oncogene 1994, 9:109-120.
21. Nakamura T, Pichel JG, Williams-Simons L, Westphal H: An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele. Proc Natl Acad Sci USA 1995, 92:6142-6146.
22. Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T: A subset of p53-deficient embryos exhibit exencephaly. Nature Genet 1995, 10:175-180.
23. Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR: High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 1995, 5:931-936.
24. Nicol CJ, Harrison ML, Laposa RR, Gimelshtein IL, Wells PG: A teratological suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nature Genet 1995, 10:181-187.
25. Knudsen TB, Winters RS, Otey SK, Blackburn MR, Airhart MJ, Church JK, Skalko RG: Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse. Teratology 1992, 45:91-103.
26. Gao X, Knudsen TB, Ibrahim MM, Haldar S: Bcl-2 relieves deoxyadenylate stress and suppresses apoptosis in pre-B leukemia cells. Cell Death Differentiation 1995, 2:69-77.
27. Carrera CJ, Terai C, Lotz M, Curd JG, Piro LD, Beutler E, Carson DA: Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo: a novel approach to immunosuppressive therapy. J Clin Inves 1990, 86:1480-1488.
28. Hirota Y, Yoshioka A, Tanaka S, Watanabe K, Otani T, Minowada J, et al.: Imbalance of deoxyribonucleoside triphosphates, DNA double strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells. Cancer Res 1989, 49:915-919.
29. Coates PJ, Save V, Ansari B, Hall PA: Demonstration of DNA damage/repair in individual cells using in situ end labelling: association of p53 with sites of DNA damage. J Pathol 1995, 176:19-26.
30. Fritsche M, Haessler C, Brandner G: Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 1993, 8:307-317.
31. Nelson WG, Kastan MB: DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 1994, 14:1815-1823.
32. Rogel M, Popliker M, Webb CG, Oren M: p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 1985, 5:2851-2855.
33. Schmid P, Lorenz A, Hameister H, Montenarh M: Expression of p53 during mouse embryogenesis. Development 1991, 113:857-865.
34. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, Hall PA: The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 1994, 54:614-617.
35. Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH: p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation. Oncogene 1994, 9:1767-1773.
36. Midgley CA, Owens B, Briscoe CV, Thomas DB, Lane DP, Hall PA: Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci 1995, 108:1843-1848.
37. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493-501.
38. Mirkes PE: Cyclophosphamide teratogenesis: a review. Teratogen Carcinogen Mutagen 1985, 5:75-88.
39. Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 1992, 11:95-103.
40. Theiler K: The House Mouse. Atlas of Embryonic Development, 2nd edn. New York: Springer-Verlag; 1989.
41. Strange R, Murphree RL: Exposure-rate responses in the prenatally irradiated rat Effect of 100 R on day 11 of gestation to the developing eye. Radiat Res 1972, 51:674-684.
42. Spaeth GL, Nelson LB, Beaudoin AR: Experimental teratogenesis. In Ocular Anatomy, Embryology, and Teratology. Edited by Jakobiec FA. Philadelphia: Harper & Row; 1982:968-981.
43. Hicks SP: Mechanism of radiation anencephaly, anophtalmia and pituitary anomalies: repair in the mammalian embryo. Arch Pathol 1954, 57:363-378.
44. Christensen N: Ocular malformations induced by radiation of the mouse embryo. Acta Pathol Microbiol Scand (Suppl) 1976, 254:1-170.
45. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deftciency in the developing mouse lens. Nature 1994, 371:72-74.
46. Fromm W, Shawlot W, Gunning K, Butel JS, Overbeek PA: The retinoblastoma protein-binding region of Simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice. Mol Cell Biol 1994, 14:6743-6754.
47. Pan H, Griep AE: Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development Genes Dev 1995, 9:2157-2169.